COVID-19 related olfactory dysfunction.
Curr Opin Otolaryngol Head Neck Surg
; 30(1): 19-25, 2022 Feb 01.
Article
in English
| MEDLINE | ID: covidwho-1612726
ABSTRACT
PURPOSE OF REVIEW This article reviews the literature on COVID-19 related anosmia, focusing on the epidemiology, pathophysiology recovery rates, current available treatment options, and research regarding novel treatments. RECENT FINDINGS:
Loss of sense of smell is one of the most prevalent symptoms reported by patients after COVID-19 infection. Even though there is a high self-reported recovery rate, recent studies have demonstrated that up to 7% of the patients remain anosmic more than 12âmonths after onset, leaving millions worldwide with severe olfactory dysfunction. Olfactory training remains the first line recommended treatment. Given the paucity of effective medical treatments options researchers are exploring novel therapeutic options.SUMMARY:
Olfactory dysfunction remains a significant and persistent legacy of the COVID-19 pandemic, but heightened awareness may stimulate research that leads to the development of much-needed treatment options.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Olfaction Disorders
Type of study:
Diagnostic study
/
Observational study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Curr Opin Otolaryngol Head Neck Surg
Journal subject:
Otolaryngology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS